Description

Decanamide, n-[(1R,2R)-2-Hydroxy-2-Phenyl-1-(1-Pyrrolidinylmethyl)Ethyl]- is a chiral amide derivative with a complex molecular architecture, designed for high-value synthetic applications. This compound matters as a sophisticated building block or intermediate in the synthesis of active pharmaceutical ingredients (APIs) and other fine chemicals, where its stereochemistry is critical for biological activity. It is primarily needed by pharmaceutical R&D teams and custom synthesis organizations focused on developing novel therapeutic agents and advanced materials.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of new drug candidates, particularly in central nervous system (CNS) or receptor-targeted therapies.
• Asymmetric Synthesis: Utilized as a ligand or precursor in catalytic asymmetric reactions to induce stereoselectivity.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Fine Chemical Production: Employed in the multi-step synthesis of complex organic molecules requiring specific stereocenters.
• Biochemical Research: Potential use as a probe or inhibitor in enzymatic studies due to its amide and hydroxy functional groups.
• Advanced Material Synthesis: May act as a monomer or functional additive in the creation of specialized polymers with tailored properties.

Basic Information

Product Name	Decanamide, n-[(1R,2R)-2-Hydroxy-2-Phenyl-1-(1-Pyrrolidinylmethyl)Ethyl]-
CAS No.	193545-89-0
Molecular Formula	C23H38N2O2
Molecular Weight	374.56 g/mol
Synonyms	(1R,2R)-N-(2-Hydroxy-2-phenylethyl)-N-(pyrrolidin-1-ylmethyl)decanamide; (1R,2R)-2-(Decanoylamino)-1-(pyrrolidin-1-ylmethyl)-2-phenylethanol; (1R,2R)-1-(Aminomethyl)-2-hydroxy-2-phenylethyl decanoate pyrrolidine derivative; N-[(1R,2R)-2-Hydroxy-1-(pyrrolidin-1-ylmethyl)-2-phenylethyl]decanamide; (R,R)-HPPME Decanamide; Decanamide HPPME derivative; Chiral Decanamide Pyrrolidinylmethyl Ethanol Derivative
EINECS	Contact for details

Quality Control

Supplied as a high-purity pharmaceutical intermediate, this product undergoes rigorous quality testing to ensure batch-to-batch consistency and compliance with relevant standards. Our quality system emphasizes identity confirmation and chiral purity as critical parameters. Comprehensive Certificates of Analysis (COA) detailing purity, enantiomeric excess, and impurity profiles are available upon request to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 97.0%
Enantiomeric Excess (Chiral HPLC)	≥ 99.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.